Effect of LY450139 on the Long Term Progression of Alzheimer's Disease

NCT00594568 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1537

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: LY450139
DRUG: Placebo

Sponsor

Eli Lilly and Company